Day: September 7, 2022

Posted on

Sardar Shahid Ahmed Laghari assumes charge as Chairperson PRCS

Karachi, September 07, 2022 (PPI-OT):Sardar Shahid Ahmed Laghari assumed the charge of Pakistan Red Crescent Society (PRCS) as Chairperson on Monday. He has 22 years of experience in the corporate and healthcare sector. Soon after his arrival at the PRCS National Headquarters, Sardar Shahid Ahmed Laghari held meetings with the management and officers of the National Society.

Secretary General briefed the new chairperson in detail on the Red Cross Red Crescent Movement, mandate and countrywide programs, interventions and operations of PRCS and assured him of full cooperation and assistance. Mr. Shahid Ahmed Laghari appreciated the role of the PRCS in mitigating the suffering of the most vulnerable. He said the PRCS was a national humanitarian organization having won international acclaim and recognition.

He stressed the need for increased commitment and dedication to help the vulnerable in a befitting manner. Honourable Chairman said that floods have caused a lot of destruction in Sindh, Balochistan, Khyber Pakhtunkhwa and South Punjab. He instructed all departments to expedite efforts for rescue, relief, and rehabilitation of the recent flood-hit population. He also inspected all departments of the Red Crescent and participated in the online meeting of the International Federation of the Red Cross (IFRC).

For more information, contact:
Sindh Provincial Branch,
Pakistan Red Crescent Society (PRCS)
Hilal-e Ahmar House, G 2 Khayaban-e-Iqbal, Zone A Block 7,
Teen Talwar, Main Clifton Road, Karachi, Pakistan
Tel: +92-21-35306227, 35306228, 35306229
Fax: +92-21-35830376
E-mail: phq@prcsindh.org.pk
Website: http://www.prcsindh.org.pk/

Posted on

IUB organized the first contract signing ceremony of its School Franchise System organized by DISS 

Bahawalpur, September 07, 2022 (PPI-OT):The Islamia University of Bahawalpur organized the first contract signing ceremony of its School Franchise System organized by Directorate of Islamia University School System (DISS) at Vice Chancellor’s Secretariat Baghdad-ul-Jadeed Campus. The ceremony was attended by Mr. Abdul Samad, Director DISS. Mr. Rizwan Majeed, Director IT and Dr. Samar Fahad, Syndicate Member. The first franchise of the Islamia University School System was obtained by Mr. Hafiz Muhammad Sikandar Shakeel from Khanpur. The tenure of this contract is 10 years.

Under the leadership of Vice Chancellor Engr. Prof. Dr. Athar Mahboob, the Islamia University of Bahawalpur becomes the first public sector university in the country to bring innovation in school education along with higher education by launching a school franchise network. Interested people from all over the country can now play a significant role to promote school education in their area by acquiring the franchise of Islamia University School System.

The Islamia University School System is a unique education system of its kind as it is flourishing under the patronage of university academia professors. Furthermore, Dr. Imran Khalid, Additional Director DISS, Rana Faraz, Deputy Director DISS, Muhammad Asif Ali, Deputy Director DISS, Kulsoom Akhtar Lecturer and Dr. Bushra Sadique, Associate Professor, attended the ceremony and congratulated the DISS on the launch of its first franchise today.

For more information, contact:
The Islamia University of Bahawalpur (IUB)
University Chowk, Gulshan Colony, Bahawalpur,
Punjab – 63100, Pakistan
Tel: +92-62-9250235
Fax: +92-62-9250335
E-mail: info@iub.edu.pk
Website: https://www.iub.edu.pk/

Posted on

Sichuan Agricultural University China sent a special letter to IUB, expressing regret and assistance for the devastation 

Bahawalpur, September 07, 2022 (PPI-OT):The ongoing aid campaign for the flood victims by the Islamia University of Bahawalpur is getting great recognition at the national and international level. China’s Sichuan Agricultural University Vice President Professor Dr. Lu Yanli wrote a special letter to Vice Chancellor the Islamia University of Bahawalpur Engr. Prof. Dr. Athar Mahboob and Director Intercropping Technology Dr. Muhammad Ali Raza and expressed his regret over the recent rains and floods in Pakistan. He also expressed his grief to the flood-affected university teachers and students and said that the teachers and students of Sichuan Agriculture University are standing with the Islamia University of Bahawalpur in the hour of trouble.

China and Pakistan have a long-standing friendship. The Islamia University of Bahawalpur and Sichuan Agriculture University are cooperating in many fields and the Islamia University of Bahawalpur sends its best students to Sichuan Agriculture University for higher education. He expressed hope that the affected students of the Islamia University of Bahawalpur will face this natural calamity steadfastly and return to their daily life as soon as possible.

The Islamia University of Bahawalpur flood relief camp has so far provided aid worth Rs 50 lac to the flood affected areas. Focal Person of the Islamia University of Bahawalpur for relief campaign for flood victims Prof. Dr. Asif Naveed Ranjha said that Bahawalpur Chamber of Commerce and Industry is also cooperating with the Islamia University of Bahawalpur in relief activities and soon the consignment of relief campaign will be sent to Rahim Yar Khan.

Senior Tutor and Chairman Department of Media and Communication Studies Prof. Dr. Abdul Wajid Khan said that in the past few days, relief materials worth Rs 25 lac were distributed by the students of Performing Art Society in the flood affected areas of Rajanpur. The faculty members of the Islamia University of Bahawalpur Rahim Yar Khan Campus distributed ration, tents and clothes to more than 40 flood affected families yesterday.

Director Rahim Yar Khan Campus Mian Muhammad Umair Ashraf said that under the supervision of Asadullah Lecturer of Mathematics Department, more than 300 flood affected families received relief goods of worth more than 10 lac including sugar, rice, dry ration, tarpals and cots. Insha Allah, Rahim Yar Khan Campus will soon distribute relief materials to more than 300 affected families in next phase.

For more information, contact:
The Islamia University of Bahawalpur (IUB)
University Chowk, Gulshan Colony, Bahawalpur,
Punjab – 63100, Pakistan
Tel: +92-62-9250235
Fax: +92-62-9250335
E-mail: info@iub.edu.pk
Website: https://www.iub.edu.pk/

Posted on

authorRizwan overtakes Babar to become No.1 batter in MRF Tyres ICC Men’s T20I Player Rankings 

Dubai, September 07, 2022 (PPI-OT):The wicket-keeper batter becomes only the third Pakistan player to be No.1 in the MRF Tyres ICC Men’s T20I Batting Rankings after Babar Azam and Misbah-ul-Haq.

Pakistan’s Mohammad Rizwan has overtaken his opening partner and Captain Babar Azam to seize the top position among batters in the MRF Tyres ICC Men’s T20I Player Rankings after the weekly update carried out on Wednesday.

Rizwan followed up his Player of the Match effort of 78 off 57 deliveries in an Asia Cup Group A match against Hong Kong with a crucial 71 off 51 against India in a Super Fours match in Dubai, to move from 796 rating points to a career-best 815 and claim the top position for the first time.

Rizwan is only the third Pakistan batter to be No. 1 in the T20I batting rankings after Babar, who has been at the top of the table for 1,155 days in all, and Misbah-ul-Haq, who was at the top for 313 days, from 20 April 2008 to 27 February 2009.

Meanwhile, Mohammad Nawaz’s match-winning 42 off 20 in the same match sees him move up 142 slots to 358th in the rankings.

India’s Suryakumar Yadav has dropped to fourth place in the latest update even as a host of players from Sri Lanka and Afghanistan have made their way up after some fine performances in the Asia Cup.

Sri Lanka openers Pathum Nissanka and Kusal Mendis have made notable progress after scoring half-centuries in a memorable win against India on Tuesday. Nissanka is up one place to eighth while Mendis has advanced 63 places to 41st position.

Dasun Shanaka (up 11 places to 39th) and Bhanuka Rajapaksa (up 31 places to 68th) have also moved up the rankings for batters while off-spinner Maheesh Theekshana has progressed five places to eighth among bowlers.

Afghanistan opener Rahmanullah Gurbaz’s Player of the Match effort of 84 off 45 balls that helped beat Sri Lanka in a group match, has helped him progress 14 places to 15th while Najeebullah Zadran has moved up two places to 28th after scoring 43 against Bangladesh. Spinners Mujeeb Ur Rehman (up three places to sixth) and Mohammad Nabi (up two places to 32nd) have also gained in the latest update.

India captain Rohit Sharma has gained four slots to reach 13th position after scoring 72 against Sri Lanka in their Super Fours match while former captain Virat Kohli has gained four places and is 29th in the list after scoring 60 against Pakistan. Ravichandran Ashwin (up eight places to 50th) and Arshdeep Singh (up 28 places to 62nd) have also progressed.

In the MRF Tyres ICC Men’s ODI Player Rankings updated after the second and third Australia versus Zimbabwe matches and the first Australia versus New Zealand match, Australia’s David Warner has moved up one place to sixth position among batters and New Zealand’s Kane Williamson up one place to 10th.

Australia fast bowler Mitchell Stark has moved up three places to 12th and leg-spinner Adam Zampa two places to 18th.

For more information, contact:
Headquarters,
International Cricket Council (ICC)
Street 69, Dubai Sports City,
Sh Mohammed Bin Zayed Road, Dubai, UAE
Phone: +97-143828800
Fax: +97-143828600
E-mail: enquiry@icc-cricket.com
Website: www.icc-cricket.com

Posted on

Zenas BioPharma Appoints Simon Lowry, M.D. as Chief Medical Officer

WALTHAM, Mass. and SHANGHAI, China, Sept. 07, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, today announced the appointment of Simon Lowry, M.D., as the company’s Chief Medical Officer. Dr. Lowry brings over 20 years of broad clinical expertise in the design and execution of early to late-stage clinical programs to Zenas, where he will lead the company’s global clinical, medical affairs, and pharmacovigilance functions.

“We are delighted to welcome Dr. Lowry to Zenas at this pivotal time for the company as we commence two phase three registration trials for our lead product candidate, obexelimab, in the fourth quarter of this year and initiate first-in-human clinical trials for multiple pipeline programs,” said Hua Mu, M.D., Ph. D, Chief Executive Officer at Zenas. “Dr. Lowry’s proven leadership, broad clinical development background, and extensive global clinical trial experience will further strengthen our ability to execute on our mission to transform the lives of patients with unmet medical needs by bringing best-in-class immune-based therapies to patients.”

Dr. Simon Lowry added, “There are many patients with autoimmune and rare diseases in need of effective new treatment options. The deeply experienced and talented Zenas team has made impressive progress advancing the company’s pipeline in a very short period of time, and I look forward to leading the ongoing advancement of Zenas’ clinical programs through commercialization while further expanding the company’s pipeline of innovative programs.”

Dr. Lowry is a medical doctor with 20 years of experience at large and emerging pharmaceutical and biotechnology companies directing successful development programs, leading clinical and medical affairs teams, and interacting with regulatory agencies across multiple areas of medicine, including rheumatology, immunology, and ophthalmology. Prior to joining Zenas, Dr. Lowry was Chief Medical Officer at Kinevant Science, a clinical-stage biopharmaceutical company focused on treating rare inflammatory and autoimmune diseases. Dr. Lowry was previously Head of Immunology R&D at Roivant Sciences, leading all development stage immunology assets into clinical development, and served as a key member of the leadership team. He also served as Chief Medical Officer at Sun Pharma North America, where he was responsible for four branded therapeutic areas (Immunology & Dermatology, Ophthalmology, Neurology and Oncology), and led all aspects of development and medical functions (including clinical development, medical information, field medical, HEOR, publications / medical communications, and operations). Early in his career, he worked at Novartis, where he served as Vice President, Global Medical Affairs Franchise Head, Immunology & Dermatology, and Pfizer, where he served in roles of increasing responsibility, including as Vice President, Oncology Medical Affairs Group Leader.

Prior to his pharmaceutical/ biotechnology career, Dr. Lowry practiced internal medicine at various institutions in the UK and Australia. He received his BA from Trinity Hall, Cambridge University, UK and his MB BChir medical degree from Cambridge University School of Clinical Medicine.

About Zenas BioPharma

Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients around the world. With clinical development and operations in the US and China, Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases. For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on Twitter at @ZenasBioPharma and LinkedIn.

Investor and Media Contact:
Joe Farmer
Zenas BioPharma
IR@zenasbio.com